TANA, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 764
EU - Europa 232
AS - Asia 125
AF - Africa 32
SA - Sud America 2
OC - Oceania 1
Totale 1.156
Nazione #
US - Stati Uniti d'America 746
SE - Svezia 64
CN - Cina 60
IT - Italia 41
GB - Regno Unito 35
SG - Singapore 35
BG - Bulgaria 32
CA - Canada 16
VN - Vietnam 16
AT - Austria 15
DE - Germania 13
NG - Nigeria 12
SN - Senegal 12
FI - Finlandia 10
CI - Costa d'Avorio 8
RU - Federazione Russa 7
HK - Hong Kong 4
TR - Turchia 4
FR - Francia 3
NL - Olanda 3
UA - Ucraina 3
BR - Brasile 2
CH - Svizzera 2
MX - Messico 2
AU - Australia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
TW - Taiwan 1
Totale 1.156
Città #
Ann Arbor 92
Woodbridge 73
Chandler 70
Fairfield 69
Ashburn 62
Santa Clara 57
Houston 50
Seattle 36
Sofia 32
Lancaster 26
Cambridge 24
Wilmington 21
New York 20
Singapore 20
Beijing 15
Vienna 15
Boardman 14
Ottawa 14
Dakar 12
Florence 12
Lagos 12
Lawrence 12
Princeton 12
Medford 11
Des Moines 10
Abidjan 8
Dearborn 8
Dong Ket 7
Detroit 6
Nanjing 6
Shanghai 6
Frankfurt am Main 5
Fuzhou 5
Jacksonville 5
Hong Kong 4
Pisa 4
Shenyang 4
Bremen 3
Istanbul 3
London 3
Ogden 3
San Diego 3
Serra 3
Washington 3
Xiamen 3
Auburn Hills 2
Campinas 2
Chengdu 2
Hicksville 2
Kunming 2
Los Angeles 2
Redwood City 2
Troina 2
Vicopisano 2
Wuhan 2
Amsterdam 1
Azor 1
Bern 1
Bishkek 1
Bordeaux 1
Bryan 1
Changsha 1
Chehalis 1
Ciampino 1
Dunoon 1
Düsseldorf 1
Edinburgh 1
Fremont 1
Guangzhou 1
Hefei 1
Hounslow 1
Indiana 1
Izmir 1
Jiaxing 1
Jinan 1
Jüchen 1
Kent 1
Milan 1
Nanchang 1
Ningbo 1
Norwalk 1
Nürnberg 1
Phoenix 1
Prague 1
Pune 1
Redmond 1
San Francisco 1
Scarborough 1
Sydney 1
Taiyuan 1
Tallinn 1
Tambov 1
Tianjin 1
Vientiane 1
Zhengzhou 1
Totale 943
Nome #
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 143
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 129
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 118
Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours 105
Alternatives to risk-reducing surgery for ovarian cancer 103
Novel insights on the malignant transformation of endometriosis into ovarian carcinoma 101
Dose-dense paclitaxel-and carboplatin-based neoadjuvant chemotherapy followed by surgery or concurrent chemoradiotherapy in cervical cancer: A preliminary analysis 100
.Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy. 90
Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study. 76
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 71
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 70
Radiotherapy as Definitive Treatment of Patients with Primary Vulvar Carcinoma Unfit for Surgery and with Recurrent Vulvar Carcinoma After Primary Radical Surgery: Results of a Retrospective Single-center Study. 62
Totale 1.168
Categoria #
all - tutte 3.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 0 0 0 0 0 24 14 16 16 9 4 4
2020/202175 2 11 1 2 1 3 18 3 8 7 1 18
2021/2022120 0 9 1 6 24 14 4 9 7 2 8 36
2022/2023241 22 37 24 12 33 27 0 18 44 0 23 1
2023/2024116 6 9 16 3 14 37 0 7 2 2 5 15
2024/2025119 2 12 0 22 43 40 0 0 0 0 0 0
Totale 1.168